The Procter Gamble Company

Warner-lambert Company

Mary E Carethers

David T Connor

Jagadish C Sircar

John S Kiely

Paul C Unangst

Charles F Schwender

Roderick J Sorenson

Robert F Bruns

Elizabeth A Johnson

Robert Wayne Glenn, Jr

Wiaczeslaw A Cetenko

Mark Richard Sine

Mark Leslie Kacher

Mark David Evans

Sarah Christine Heilshorn

Mannie Lee Clapp

Raymond Edward Bolich, Jr

Robert Gregory Bartolo

James Charles Dunbar

Fernando Ray Tollens

Lawrence A Gilbert

David John Weisgerber

James E Taneri

Christopher Dean Putman

Robert Raymond Schmidt

Wayne Ellis Eccard

Kevin Lee Hartzler

Dawn M French

Natalie M Moroney

Gerald L Cantey

Anna Reavis Husk

Raphael Warren

Kathleen Grieshop Baier

Peter William Beerse

Jeffrey Michael Morgan

Theresa Anne Bakken

Richard W Schell

Wiaczeslaw A Centenko

The present invention relates to a rinse-off antimicrobial cleansing composition comprising from about 0.001% to about 5% of an antimicrobial active, from about 1% to about 80% of an anionic surfactant, from about 0.1% to about 12% of a proton donating agent; from about 0.1% to about 30% of a deposition aid; and from about 3% to about 98.8% of water, wherein the composition is adjusted to a pH of from about 3.0 to about 6.0, wherein the rinse-off antimicrobial cleansing composition has a Gram Negative Residual Effectiveness Index of greater than about 0.3, and wherein the rinse-off antimicrobial cleansing composition has a Mildness Index of greater than 0.3. The invention also encompasses methods for cleansing skin and providing residual effectiveness versus Gram negative bacteria using these products.

Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria

Disclosed is a stress stable lathering skin cleansing liquid composition comprising by weight parts of the liquid composition:

Crystalline hydroxy waxes as oil in water stabilizers for skin cleansing

The present invention relates to a stress stable lathering skin cleansing liquid composition comprising by weight parts of the liquid composition:

Liquid personal cleansing compositions which comprise a complex coascervate, a lipophilic skin moisturizing agent, a stabilizer, a lathering surfactant and water are disclosed. The complex coascervate comprises particles having a particle size distribution such that at least about 10% by weight of the particles have a diameter of at least about 20 microns. The particles comprising the complex coascervate comprise 1) a polycation having a minimum filtrate with of about 10 grams, and 2) a polyanion. The complex coascervate is essentially free of cross-linking agent.

Liquid personal cleansing compositions which contain a complex

Liquid personal cleansing compositions which comprise from about 1% to about 35% of encapsulated lipophilic skin moisturizing agents, from about 0.1% to about 5% of a stabilizer, from about 5% to about 30% of a lathering surfactant and water are disclosed. The encapsulated lipophilic skin moisturizing agent comprises a lipophilic skin moisturizing agent encapsulated within a complex coascervate comprising a polycation and a polyanion. The lipophilic skin moisturizing agent comprises droplets having a particle size distribution such that at least about 10% by weight of the droplets have a diameter of at least about 100 microns. The encapsulated lipophilic skin moisturizing agent is essentially free of cross-linking agent.

Liquid personal cleansing compositions which contain an encapsulated

Liquid personal cleansing compositions which comprise a complex coacervate, a lipophilic skin moisturizing agent, a stabilizer, a lathering surfactant and water are disclosed. The complex coacervate comprises particles having a particle size distribution such that at least about 10% by weight of the particles have a diameter of at least about 20 microns. The particles comprising the complex coacervate comprise 1) a polycation having a minimum filtrate with of about 10 grams, and 2) a polyanion. The complex coacervate is essentially free of cross-linking agent.

A method for preparing moisturizing liquid personal cleansing compositions comprising preparing an encapsulated lipophilic skin moisturizing agent, mixing the encapsulated lipophilic skin moisturizing agent into a liquid personal cleansing matrix, and processing and packaging the resulting mixture. The final liquid personal cleansing composition product comprises a lipophilic skin moisturizing agent comprised of droplets having a particle size distribution such that at least about 10% by weight of the droplets have a diameter of greater than about 100 microns.

Method for preparing moisturizing liquid personal cleansing compostions

The present invention relates to an improved freezer bar soap comprising selected saturated C.sub.14 -C.sub.18 fatty acid soaps and lathering soap selected from lauric, oleic, and other minor selected more soluble soaps. The bars of this invention have improved mildness while maintaining acceptable lathering/sudsing characteristics.

Freezer personal cleansing bar with selected fatty acid soaps for

The present invention relates to an improved freezer bar soap comprising selected saturated C.sub.14 -C.sub.18 fatty acid soaps and lathering synthetic surfactant. The bars of this invention have reduced bathtub ring, as well as improved mildness while maintaining acceptable lathering/sudsing characteristics.

Personal cleansing freezer bar with selected fatty acid soaps and

The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.

Enolamides, pharmaceutical compositions and methods of use thereof for

The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and method of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.

Novel enolamides, pharmaceutical compositions and methods of use thereof

Growing community of inventors

Cincinnati, OH, United States of America

Mary E Carethers